CR04583-2024

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 17-12-A - List of Top 100 Stockholders (Common Shares) Reference: Section 17.12 of the Revised Disclosure Rules

Type of Securities

For the period ended Jun 30, 2024
Description of the Disclosure

Top 100 Stockholders and Beneficial Owners as of 30 June 2024

Number of Issued Common Shares 4,112,140,540
Number of Treasury Common Shares, if any 0
Number of Outstanding Common Shares 4,112,140,540
Number of Listed Common Shares 4,112,140,540
Number of Lodged Common Shares 38,229,249
  PCD Nominee - Filipino 37,230,625
  PCD Nominee - Non-Filipino 998,624
Number of Certificated Common Shares 4,073,911,291
Change from previous submission

None

Filed on behalf by:
Name Janice Ong
Designation Corporate Secretary